Carboxymethylierte Galactomannanprodukte als galenische Hilfsstoffe = Galactomannanes carboxyméthylés comme excipients 2nd Commun: examination microscopique et sorption d'eau = Carboxy methylated galactomannanes for use as excipients 2nd Commun: microscopic examination and sorption of waterNÜRNBERG, E; PRÜTTING, D.Acta pharmaceutica technologica. 1984, Vol 30, Num 1, pp 50-55, issn 0340-3157Article

Excipient functionalityMORETON, R. Christian.Pharmaceutical technology (2003). 2004, Vol 28, Num 5, pp 98-99, issn 1543-2521, 2 p., 119 [3 p.]Article

Synthetic excipients challenge all-natural organics: Offer advantages/challenges to developers and formulatorsRUSSELL, Ronnelle.Pharmaceutical technology (2003). 2004, Vol 28, Num 4, pp 38-50, issn 1543-2521, 7 p.Article

The bioterrorism Act: Its effect on the import and registration of pharmaceutical excipientsFALK, Arthur J.Pharmaceutical technology (2003). 2004, Vol 28, Num 1, pp 78-84, issn 1543-2521, 4 p.Article

Xylan: a possible filler and disintegrant for tabletsJUSLIN, M; PARONEN, P.Journal of pharmacy and pharmacology. 1984, Vol 36, Num 4, pp 256-257, issn 0022-3573Article

Les édulcorants = SweetenersHERAUD, G.Gazette médicale de France (1969). 1984, Vol 91, Num 11, pp 95-100, issn 0016-5557, 4 p.Article

Crystallization of excipients in tabletsANDO, H; WATANABE, S; OHWAKI, T et al.Journal of pharmaceutical sciences. 1985, Vol 74, Num 2, pp 128-131, issn 0022-3549Article

Carboxymethylierte Galaktomannan-Produkte als Galenische Hifsstoffe. III: Carboxymethyl-Galaktomannane als Matrixbildner für Retard-Zubereitungen = Les galactomannanes carboxyméthyles comme adjuvant galénique III: Les galactomannanes comme matrice pour les formulations de formes retard = Carboxymethylated galactomannan products as galenic inactive ingredientsNÜRNBERG, E; PRÜTTING, D.Pharmazeutische Industrie. 1984, Vol 46, Num 2, pp 184-186, issn 0031-711XArticle

Evaluation of cyclodextrin polymer as an additive for furosemide tabletFENYVESI, E; TAKAYAMA, K; SZEJTLI, J et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 670-677, issn 0009-2363Article

Compression characteristics of basic tricalcium phosphate (Ca₃(PO₄)₂, Ca(OH)₂)XIN PU HOU; CARSTENSEN, J. T.International journal of pharmaceutics. 1985, Vol 25, Num 2, pp 207-215, issn 0378-5173Article

Papers presented at the polymers as drug release agents symposium, 23 March 1983 at the Society of Chemical Industry, LondonBritish polymer journal. 1983, Vol 15, Num 4, issn 0007-1641, 86 p.Conference Proceedings

Anthralin stability in various vehiclesGREEN, P. G; KENNEDY, C. T. C; FORBES, D. R et al.Journal of the American Academy of Dermatology. 1987, Vol 16, Num 5, pp 984-988, issn 0190-9622, 1Article

Bestimmung der Helikalität gelöster Gelatine = Détermination de l'hélicité de la gélatine dissoute = Determination of the helicality of dissolved gelatineHÜTTENRAUCH, R; FRICKE, S; ZIELKE, P et al.Pharmazie. 1984, Vol 39, Num 5, issn 0031-7144, 350Article

Bestimmung des Ölverhaltens von weissem Vselin DAB 8 = Absorption d'huile par les vaselines blanches DAB8 = Oil absorption of white petrolatum DAB8SCHMIEDEL, R.Acta pharmaceutica technologica. 1984, Vol 30, Num 1, pp 78-84, issn 0340-3157Article

Properties of cyclodextrin polymer as a tabletting aidFENYVESI, E; SHIRAKURA, O; SZEJTLI, J et al.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 665-669, issn 0009-2363Article

Solubility of acetazolamide and chlorthalidone in mixed aqueous solvent systemIBRAHIM, S. A; SHAWKY, S.Pharmazeutische Industrie. 1984, Vol 46, Num 4, pp 412-416, issn 0031-711XArticle

Polymer effects on ocular bioavailability: the influence of different liquid vehicles on the mydriatic response of tropicamide in humans and in rabbitsSAETTONE, M. F; GIANNACCINI, B; RAVECCA, S et al.International journal of pharmaceutics. 1984, Vol 20, Num 1-2, pp 187-202, issn 0378-5173Article

Sorption und oxidative Veränderungen von 3-Butylhydroxyanisol (3-BHA) in SiO₂-Dispersionen. I: Sorptionsverhalten von 3-BHA = Adsorption et altération oxydatives de l'anisol (butylhydroxy-3) dans des dispersions de silice = Adsorption and oxidative alterations of 3-butylhydroxyanisole (3-BHA) in silica dispersionsTISCHINGER-WAGNER, H; RUPPRECHT, H.Pharmazeutische Industrie. 1984, Vol 46, Num 3, pp 275-278, issn 0031-711XArticle

Drug-drug incompatibility in the solid state: kinetic interpretation, modelling and predictionLI WAN PO, A; MROSO, P. V.International journal of pharmaceutics. 1984, Vol 18, Num 3, pp 287-298, issn 0378-5173Article

Comparative evaluation of maltose as excipient for direct compressionMICHOEL, A; ROMBAUT, P; KINGET, R et al.Pharmazeutische Industrie. 1983, Vol 45, Num 9, pp 892-896, issn 0031-711XArticle

Examination of natural gums as matrices for sustained release of theophyllineNAKANO, M; OGATA, A.Chemical and pharmaceutical bulletin. 1984, Vol 32, Num 2, pp 782-785, issn 0009-2363Article

The effect of film-inducing substances on the characteristics of binary powder mixturesSAMAHA, M. W; EL GINDY, N. A.International journal of pharmaceutics. 1984, Vol 19, Num 1, pp 63-74, issn 0378-5173Article

Dissolution testing using continuous multicomponent UV analysis to correct for excipient interferenceANDERSON, N. H; JOHNSTON, D; VOJVODIC, P. R et al.Journal of pharmaceutical and biomedical analysis. 1990, Vol 8, Num 8-12, pp 987-989, issn 0731-7085, 3 p.Conference Paper

Möglichkeiten zur Bestimmung der Wirkstoffreigabe aus hydrophoben Trägern, insbesondere aus Suppositorien = Possibilités pour la détermination de la libération de principe actif à partir de supports hydrophobes en particulier à partir des suppositoires = Alternative technique for the determination of drug release from hydrophobic matrix particularly suppositoriesDIBBERN, H.-W; WIRBITZKI, E.Pharmazeutische Industrie. 1983, Vol 45, Num 10, pp 985-990, issn 0031-711XArticle

Poly(ethylene glycol) quantitation by laser nephelometryCOLE, S. C; CHRISTENSEN, G. A; OLSON, W. P et al.Analytical biochemistry. 1983, Vol 134, Num 2, pp 368-373, issn 0003-2697Article